Gestational Hypertension and High-Density Lipoprotein Function: An Explorative Study in Overweight/Obese Women of the DALI Cohort

Gestational hypertension (GHTN) is associated with an increased cardiovascular risk for mothers and their offspring later in life. High-density lipoproteins (HDL) are anti-atherogenic by promoting efflux of cholesterol from macrophages and suppression of endothelial cell activation. Functional impai...

Full description

Bibliographic Details
Published in:	Antioxidants
Main Authors:	Julia T. Stadler, M. N. M. van Poppel, Christina Christoffersen, David Hill, Christian Wadsack, David Simmons, Gernot Desoye, Gunther Marsche, DALI Core Investigator Group
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	gestational hypertension HDL cholesterol efflux capacity paraoxonase-1 apolipoprotein M pregnancy
Online Access:	https://www.mdpi.com/2076-3921/12/1/68

Similar Items

Obesity Affects Maternal and Neonatal HDL Metabolism and Function
by: Julia T. Stadler, et al.
Published: (2023-01-01)

Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies
by: Gunther Marsche, et al.
Published: (2022-03-01)

The Association of Physical Activity and Sedentary Behavior with Maternal and Cord Blood Anti-Oxidative Capacity and HDL Functionality: Findings of DALI Study
by: Saghi Zafaranieh, et al.
Published: (2023-03-01)

Preeclampsia Affects Lipid Metabolism and HDL Function in Mothers and Their Offspring
by: Julia T. Stadler, et al.
Published: (2023-03-01)

HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients [S]
by: Kathrin Untersteller, et al.
Published: (2018-01-01)

Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease
by: Gunther Marsche, et al.
Published: (2020-09-01)

HDL structure and function is profoundly affected when stored frozen in the absence of cryoprotectants
by: Michael Holzer, et al.
Published: (2017-11-01)

High-density lipoprotein cholesterol efflux capacity in patients with obstructive sleep apnea and its relation with disease severity
by: Reza Fadaei, et al.
Published: (2022-11-01)

A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease
by: Alankrita Rani, et al.
Published: (2023-05-01)

Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease
by: Julia T. Stadler, et al.
Published: (2021-03-01)

CRISPR/dCas9 Transcriptional Activation of Endogenous Apolipoprotein AI and Paraoxonase 1 in Enterocytes Alleviates Endothelial Cell Dysfunction
by: Laura Toma, et al.
Published: (2021-11-01)

Association of human apolipoprotein E with lipoproteins secreted by transfected McA RH7777 cells
by: Catherine A. Reardon, et al.
Published: (1998-07-01)

Cuban policosanol improves high-density lipoprotein cholesterol efflux capacity in healthy Japanese subjects
by: Yoshinari Uehara, et al.
Published: (2024-01-01)

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
by: Ewa Wieczorek, et al.
Published: (2021-12-01)

Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes
by: Damien Denimal
Published: (2023-12-01)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
by: Angelo Zinellu, et al.
Published: (2023-07-01)

Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents
by: Skylar T. Chuang, et al.
Published: (2020-05-01)

Association of Small HDL Subclasses with Mortality Risk in Chronic Kidney Disease
by: Julia T. Stadler, et al.
Published: (2024-12-01)

Human apoA-I[Lys107del] mutation affects lipid surface behavior of apoA-I and its ability to form large nascent HDL
by: Irina N. Gorshkova, et al.
Published: (2023-02-01)

Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1
by: Karen Y.Y. Fung, et al.
Published: (2024-04-01)

ATP hydrolysis-dependent conformational changes in the extracellular domain of ABCA1 are associated with apoA-I binding[S]
by: Kohjiro Nagao, et al.
Published: (2012-01-01)

High-Density Lipoprotein (HDL) in Allergy and Skin Diseases: Focus on Immunomodulating Functions
by: Athina Trakaki, et al.
Published: (2020-12-01)

Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside
by: Alexandre Mezentsev, et al.
Published: (2021-05-01)

Effect of Dietary PUFAs and Antioxidants on Antioxidant and Anti-Inflammatory Functions of HDL in a Cohort of Women
by: Gianmarco Mola, et al.
Published: (2025-10-01)

Paraoxonase 1 as an important antiatherogenic agent
by: Ewa Lidia Krzewicka-Romaniuk, et al.
Published: (2019-01-01)

Association between HDL Particles Size and Myeloperoxidase/ Paraoxonase-1 (MPO/PON1) Ratio in Patients with Acute Coronary Syndrome
by: Amirnader Emami Razavi, et al.
Published: (2013-06-01)

Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19
by: Julia T. Stadler, et al.
Published: (2022-09-01)

The Predictive Value of miR-16, -29a and -134 for Early Identification of Gestational Diabetes: A Nested Analysis of the DALI Cohort
by: Anja Elaine Sørensen, et al.
Published: (2021-01-01)

Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population
by: Tara R. Price, et al.
Published: (2023-12-01)

Caffeine Increases Apolipoprotein A-1 and Paraoxonase-1 but not Paraoxonase-3 Protein Levels in Human-Derived Liver (HepG2) Cells
by: Gülben Sayılan Özgün, et al.
Published: (2017-12-01)

HDL-Related Parameters and COVID-19 Mortality: The Importance of HDL Function
by: Julia T. Stadler, et al.
Published: (2023-11-01)

Impact of metabolic-associated fatty liver disease on the cholesterol efflux capacity of high-density lipoproteins in adolescents with type 2 diabetes
by: José Antonio Orozco Morales, et al.
Published: (2024-12-01)

ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid
by: Edward B. Neufeld, et al.
Published: (2019-07-01)

The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender
by: Hamit Yasar Ellidag, et al.
Published: (2016-12-01)

Baculovirus-mediated expression and purification of human serum paraoxonase 1A
by: Robert J. Brushia, et al.
Published: (2001-06-01)

Impaired HDL antioxidant and anti-inflammatory functions are linked to increased mortality in acute heart failure patients
by: Anja Pammer, et al.
Published: (2024-10-01)

High-Density Lipoprotein Changes in Alzheimer’s Disease Are <i>APOE</i> Genotype-Specific
by: Brian V. Hong, et al.
Published: (2022-06-01)

Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
by: Nicolas Vuilleumier, et al.
Published: (2013-05-01)

Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins
by: Athina Trakaki, et al.
Published: (2021-05-01)

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
by: Anouar Hafiane, et al.
Published: (2022-04-01)